Updated European Consensus Statement on diagnosis and treatment of adult ADHD

J. J. S. Kooij; D. Bijlenga; L. Salerno; R. Jaeschke; I. Bitter; J. Balázs; J. Thome; Geert Dom; S. Kasper; C. Nunes Filipe; S. Stes; Pavel Mohr; S. Leppämäki; Miquel Casas Brugué; Julio Bobes; J. M. Mccarthy; Vanesa Richarte; A. Kjems Philipsen; A. Pehlivanidis; A. Niemela; B. Styr; B. Semerci; B. Bolea-Alamanac; Dan Edvinsson; D. Baeyens; D. Wynchank; E. Sobanski; A. Philipsen; Herve Caci; I. Mihailescu; I. Manor; I. Dobrescu; J. Krause; John Fayyad; Josep Antoni Ramos-Quiroga; K. Foeken; F. Rad; M. Adamou; M. Ohlmeier; M. Fitzgerald; M. Gill; M. Lensing; N. Motavalli Mukaddes; P. Brudkiewicz; P. Gustafsson; P. Tani; Pieter Jan Carpentier; P. De Rossi; R. Delorme; S. Markovska Simoska; S. Pallanti; S. Young; Susanne Bejerot; T. Lehtonen; J. Kustow; U. Müller-Sedgwick; T. Hirvikoski; V. Pironti; Y. Ginsberg; Z. Félegeházy; Maria-Paz García-Portilla; Philip Asherson

doi:10.1016/j.eurpsy.2018.11.001

Updated European Consensus Statement on diagnosis and treatment of adult ADHD

J. J. S. Kooij, D. Bijlenga, L. Salerno, R. Jaeschke, I. Bitter, J. Balázs, J. Thome, Geert Dom, S. Kasper, C. Nunes Filipe, S. Stes, Pavel Mohr, S. Leppämäki, Miquel Casas Brugué, Julio Bobes, J. M. Mccarthy, Vanesa Richarte, A. Kjems Philipsen, A. Pehlivanidis, A. NiemelaB. Styr, B. Semerci, B. Bolea-Alamanac, Dan Edvinsson, D. Baeyens, D. Wynchank, E. Sobanski, A. Philipsen, Herve Caci, I. Mihailescu, I. Manor, I. Dobrescu, J. Krause, John Fayyad, Josep Antoni Ramos-Quiroga, K. Foeken, F. Rad, M. Adamou, M. Ohlmeier, M. Fitzgerald, M. Gill, M. Lensing, N. Motavalli Mukaddes, P. Brudkiewicz, P. Gustafsson, P. Tani, Pieter Jan Carpentier, P. De Rossi, R. Delorme, S. Markovska Simoska, S. Pallanti, S. Young, Susanne Bejerot, T. Lehtonen, J. Kustow, U. Müller-Sedgwick, T. Hirvikoski, V. Pironti, Y. Ginsberg, Z. Félegeházy, Maria-Paz García-Portilla, Philip Asherson

Departament de Psiquiatria i Medicina Legal

Producció científica: Contribució a revista › Article › Recerca › Avaluat per experts

451 Cites (Scopus)

Resum

Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD is currently underdiagnosed and undertreated in many European countries, leading to chronicity of symptoms and impairment, due to lack of, or ineffective treatment, and higher costs of illness. Methods The European Network Adult ADHD and the Section for Neurodevelopmental Disorders Across the Lifespan (NDAL) of the European Psychiatric Association (EPA), aim to increase awareness and knowledge of adult ADHD in and outside Europe. This Updated European Consensus Statement aims to support clinicians with research evidence and clinical experience from 63 experts of European and other countries in which ADHD in adults is recognized and treated. Results Besides reviewing the latest research on prevalence, persistence, genetics and neurobiology of ADHD, three major questions are addressed: (1) What is the clinical picture of ADHD in adults? (2) How should ADHD be properly diagnosed in adults? (3) How should adult ADHDbe effectively treated? Conclusions ADHD often presents as a lifelong impairing condition. The stigma surrounding ADHD, mainly due to lack of knowledge, increases the suffering of patients. Education on the lifespan perspective, diagnostic assessment, and treatment of ADHD must increase for students of general and mental health, and for psychiatry professionals. Instruments for screening and diagnosis of ADHD in adults are available, as are effective evidence-based treatments for ADHD and its negative outcomes. More research is needed on gender differences, and in older adults with ADHD.

Idioma original	Anglès
Pàgines (de-a)	14-34
Nombre de pàgines	21
Revista	European Psychiatry
Volum	56
DOIs	https://doi.org/10.1016/j.eurpsy.2018.11.001
Estat de la publicació	Publicada - 2019

SDG de les Nacions Unides

Aquest resultat contribueix als següents objectius de desenvolupament sostenible.

Accés al document

10.1016/j.eurpsy.2018.11.001

https://ddd.uab.cat/record/223450

Altres arxius i enllaços

https://www.scopus.com/pages/publications/85056845323

Com citar-ho

Kooij, J. J. S., Bijlenga, D., Salerno, L., Jaeschke, R., Bitter, I., Balázs, J., Thome, J., Dom, G., Kasper, S., Nunes Filipe, C., Stes, S., Mohr, P., Leppämäki, S., Casas Brugué, M., Bobes, J., Mccarthy, J. M., Richarte, V., Kjems Philipsen, A., Pehlivanidis, A., ... Asherson, P. (2019). Updated European Consensus Statement on diagnosis and treatment of adult ADHD. European Psychiatry, 56, 14-34. https://doi.org/10.1016/j.eurpsy.2018.11.001

@article{674cd6febcd34761a9802ecf236f1b8b,

title = "Updated European Consensus Statement on diagnosis and treatment of adult ADHD",

abstract = "Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD is currently underdiagnosed and undertreated in many European countries, leading to chronicity of symptoms and impairment, due to lack of, or ineffective treatment, and higher costs of illness. Methods The European Network Adult ADHD and the Section for Neurodevelopmental Disorders Across the Lifespan (NDAL) of the European Psychiatric Association (EPA), aim to increase awareness and knowledge of adult ADHD in and outside Europe. This Updated European Consensus Statement aims to support clinicians with research evidence and clinical experience from 63 experts of European and other countries in which ADHD in adults is recognized and treated. Results Besides reviewing the latest research on prevalence, persistence, genetics and neurobiology of ADHD, three major questions are addressed: (1) What is the clinical picture of ADHD in adults? (2) How should ADHD be properly diagnosed in adults? (3) How should adult ADHDbe effectively treated? Conclusions ADHD often presents as a lifelong impairing condition. The stigma surrounding ADHD, mainly due to lack of knowledge, increases the suffering of patients. Education on the lifespan perspective, diagnostic assessment, and treatment of ADHD must increase for students of general and mental health, and for psychiatry professionals. Instruments for screening and diagnosis of ADHD in adults are available, as are effective evidence-based treatments for ADHD and its negative outcomes. More research is needed on gender differences, and in older adults with ADHD.",

author = "Kooij, \{J. J. S.\} and D. Bijlenga and L. Salerno and R. Jaeschke and I. Bitter and J. Bal{\'a}zs and J. Thome and Geert Dom and S. Kasper and \{Nunes Filipe\}, C. and S. Stes and Pavel Mohr and S. Lepp{\"a}m{\"a}ki and \{Casas Brugu{\'e}\}, Miquel and Julio Bobes and Mccarthy, \{J. M.\} and Vanesa Richarte and \{Kjems Philipsen\}, A. and A. Pehlivanidis and A. Niemela and B. Styr and B. Semerci and B. Bolea-Alamanac and Dan Edvinsson and D. Baeyens and D. Wynchank and E. Sobanski and A. Philipsen and Herve Caci and I. Mihailescu and I. Manor and I. Dobrescu and J. Krause and John Fayyad and Ramos-Quiroga, \{Josep Antoni\} and K. Foeken and F. Rad and M. Adamou and M. Ohlmeier and M. Fitzgerald and M. Gill and M. Lensing and \{Motavalli Mukaddes\}, N. and P. Brudkiewicz and P. Gustafsson and P. Tani and Carpentier, \{Pieter Jan\} and \{De Rossi\}, P. and R. Delorme and \{Markovska Simoska\}, S. and S. Pallanti and S. Young and Susanne Bejerot and T. Lehtonen and J. Kustow and U. M{\"u}ller-Sedgwick and T. Hirvikoski and V. Pironti and Y. Ginsberg and Z. F{\'e}legeh{\'a}zy and Maria-Paz Garc{\'i}a-Portilla and Philip Asherson",

year = "2019",

doi = "10.1016/j.eurpsy.2018.11.001",

language = "English",

volume = "56",

pages = "14--34",

}

Kooij, JJS, Bijlenga, D, Salerno, L, Jaeschke, R, Bitter, I, Balázs, J, Thome, J, Dom, G, Kasper, S, Nunes Filipe, C, Stes, S, Mohr, P, Leppämäki, S, Casas Brugué, M, Bobes, J, Mccarthy, JM, Richarte, V, Kjems Philipsen, A, Pehlivanidis, A, Niemela, A, Styr, B, Semerci, B, Bolea-Alamanac, B, Edvinsson, D, Baeyens, D, Wynchank, D, Sobanski, E, Philipsen, A, Caci, H, Mihailescu, I, Manor, I, Dobrescu, I, Krause, J, Fayyad, J, Ramos-Quiroga, JA, Foeken, K, Rad, F, Adamou, M, Ohlmeier, M, Fitzgerald, M, Gill, M, Lensing, M, Motavalli Mukaddes, N, Brudkiewicz, P, Gustafsson, P, Tani, P, Carpentier, PJ, De Rossi, P, Delorme, R, Markovska Simoska, S, Pallanti, S, Young, S, Bejerot, S, Lehtonen, T, Kustow, J, Müller-Sedgwick, U, Hirvikoski, T, Pironti, V, Ginsberg, Y, Félegeházy, Z, García-Portilla, M-P & Asherson, P 2019, 'Updated European Consensus Statement on diagnosis and treatment of adult ADHD', European Psychiatry, vol. 56, pàg. 14-34. https://doi.org/10.1016/j.eurpsy.2018.11.001

TY - JOUR

T1 - Updated European Consensus Statement on diagnosis and treatment of adult ADHD

AU - Kooij, J. J. S.

AU - Bijlenga, D.

AU - Salerno, L.

AU - Jaeschke, R.

AU - Bitter, I.

AU - Balázs, J.

AU - Thome, J.

AU - Dom, Geert

AU - Kasper, S.

AU - Nunes Filipe, C.

AU - Stes, S.

AU - Mohr, Pavel

AU - Leppämäki, S.

AU - Casas Brugué, Miquel

AU - Bobes, Julio

AU - Mccarthy, J. M.

AU - Richarte, Vanesa

AU - Kjems Philipsen, A.

AU - Pehlivanidis, A.

AU - Niemela, A.

AU - Styr, B.

AU - Semerci, B.

AU - Bolea-Alamanac, B.

AU - Edvinsson, Dan

AU - Baeyens, D.

AU - Wynchank, D.

AU - Sobanski, E.

AU - Philipsen, A.

AU - Caci, Herve

AU - Mihailescu, I.

AU - Manor, I.

AU - Dobrescu, I.

AU - Krause, J.

AU - Fayyad, John

AU - Ramos-Quiroga, Josep Antoni

AU - Foeken, K.

AU - Rad, F.

AU - Adamou, M.

AU - Ohlmeier, M.

AU - Fitzgerald, M.

AU - Gill, M.

AU - Lensing, M.

AU - Motavalli Mukaddes, N.

AU - Brudkiewicz, P.

AU - Gustafsson, P.

AU - Tani, P.

AU - Carpentier, Pieter Jan

AU - De Rossi, P.

AU - Delorme, R.

AU - Markovska Simoska, S.

AU - Pallanti, S.

AU - Young, S.

AU - Bejerot, Susanne

AU - Lehtonen, T.

AU - Kustow, J.

AU - Müller-Sedgwick, U.

AU - Hirvikoski, T.

AU - Pironti, V.

AU - Ginsberg, Y.

AU - Félegeházy, Z.

AU - García-Portilla, Maria-Paz

AU - Asherson, Philip

PY - 2019

Y1 - 2019

N2 - Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD is currently underdiagnosed and undertreated in many European countries, leading to chronicity of symptoms and impairment, due to lack of, or ineffective treatment, and higher costs of illness. Methods The European Network Adult ADHD and the Section for Neurodevelopmental Disorders Across the Lifespan (NDAL) of the European Psychiatric Association (EPA), aim to increase awareness and knowledge of adult ADHD in and outside Europe. This Updated European Consensus Statement aims to support clinicians with research evidence and clinical experience from 63 experts of European and other countries in which ADHD in adults is recognized and treated. Results Besides reviewing the latest research on prevalence, persistence, genetics and neurobiology of ADHD, three major questions are addressed: (1) What is the clinical picture of ADHD in adults? (2) How should ADHD be properly diagnosed in adults? (3) How should adult ADHDbe effectively treated? Conclusions ADHD often presents as a lifelong impairing condition. The stigma surrounding ADHD, mainly due to lack of knowledge, increases the suffering of patients. Education on the lifespan perspective, diagnostic assessment, and treatment of ADHD must increase for students of general and mental health, and for psychiatry professionals. Instruments for screening and diagnosis of ADHD in adults are available, as are effective evidence-based treatments for ADHD and its negative outcomes. More research is needed on gender differences, and in older adults with ADHD.

AB - Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD is currently underdiagnosed and undertreated in many European countries, leading to chronicity of symptoms and impairment, due to lack of, or ineffective treatment, and higher costs of illness. Methods The European Network Adult ADHD and the Section for Neurodevelopmental Disorders Across the Lifespan (NDAL) of the European Psychiatric Association (EPA), aim to increase awareness and knowledge of adult ADHD in and outside Europe. This Updated European Consensus Statement aims to support clinicians with research evidence and clinical experience from 63 experts of European and other countries in which ADHD in adults is recognized and treated. Results Besides reviewing the latest research on prevalence, persistence, genetics and neurobiology of ADHD, three major questions are addressed: (1) What is the clinical picture of ADHD in adults? (2) How should ADHD be properly diagnosed in adults? (3) How should adult ADHDbe effectively treated? Conclusions ADHD often presents as a lifelong impairing condition. The stigma surrounding ADHD, mainly due to lack of knowledge, increases the suffering of patients. Education on the lifespan perspective, diagnostic assessment, and treatment of ADHD must increase for students of general and mental health, and for psychiatry professionals. Instruments for screening and diagnosis of ADHD in adults are available, as are effective evidence-based treatments for ADHD and its negative outcomes. More research is needed on gender differences, and in older adults with ADHD.

UR - https://www.scopus.com/pages/publications/85056845323

U2 - 10.1016/j.eurpsy.2018.11.001

DO - 10.1016/j.eurpsy.2018.11.001

M3 - Article

SN - 0924-9338

VL - 56

SP - 14

EP - 34

JO - European Psychiatry

JF - European Psychiatry

ER -

Updated European Consensus Statement on diagnosis and treatment of adult ADHD

Resum

SDG de les Nacions Unides

Accés al document

Altres arxius i enllaços

Fingerprint

Com citar-ho